Cell-free DNA screening for trisomies 21, 18, and 13: Clinical application and accuracy evaluation
PLOS One · 2025
DOI: 10.1371/journal.pone.0332081 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Xiangmei Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Down Syndrome, Trisomy 13 Syndrome, Trisomy 18 Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cell-free DNA (cf-DNA) screening for common trisomies has been increasingly assimilated into prenatal care. In this study, we evaluated the Z-score accuracy and the effectiveness of non-invasive prenatal testing (NIPT) for trisomies 21, 18, and 13 using cf-DNA, and further analyze pregnancy outcomes of NIPT-positive pregnant women.
Methods
This retrospective study analyzed pregnancies that yielded positive NIPT results at Shaoxing Maternity and Child Health Care Hospital between 01/01/2017 and 31/12/2022. Invasive prenatal diagnosis (IPD) confirmed the positive NIPT findings. Logistic regression analysis was applied to correlation analysis of Z-scores and positive predictive value (PPV). Accuracy of Z-score was evaluated through receiver operating characteristic (ROC) curve analysis. Data regarding basic characteristics, prenatal diagnosis results, and pregnancy outcomes were collected.
Results
In total,257 high-risk cases of trisomy 21, 18, and 13 were identified. Among these,193 pregnancies underwent invasive prenatal diagnosis (IPD) in our institution, the PPV was 75.44% for T21,45.28% for T18, and 17.86% for T13. A significant association between Z-scores and PPVs were revealed by logistic regression(p < 0.05). The ROC curve analysis revealed optimal cutoff values of 7.231 for T21, 5.245 for T18, and 7.504 for T13. The corresponding areas under the curve (AUC) were 0.954, 0.941, and 0.924, respectively. Moreover, the PPV was statistically higher in the very-high-risk (VHR) group than in the general high-risk (GHR) group. In terms of pregnancy outcomes,98.51% (132/134) of pregnancies identified with chromosomal abnormalities were terminated, whereas 98.89% (89/90) of those diagnosed with false-positive results were carried to term.
Conclusions
The study demonstrates that the Z-score is valuable in accurately assessing NIPT results. Consequently, clinicians can provide more efficient prenatal genetic counseling by utilizing a specific reference value for the Z-score.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China.
- Maternity and Child Health Care Affiliated Hospital, Shaoxing University, Shaoxing, China.
- Department of Prenatal Diagnosis Medical Center, Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China.
ORCID-Profile: Xiaoliang Shi
Zitieren
APA
Sun, X., Ying, Y., Chen, C., & Shi, X. (2025). Cell-free DNA screening for trisomies 21, 18, and 13: Clinical application and accuracy evaluation. PLOS One. https://doi.org/10.1371/journal.pone.0332081
Vancouver
Sun X, Ying Y, Chen C, Shi X. Cell-free DNA screening for trisomies 21, 18, and 13: Clinical application and accuracy evaluation. PLOS One. 2025. doi:10.1371/journal.pone.0332081
BibTeX
@article{Sun2025,
author = {Sun, Xiangmei and Ying, Yuyi and Chen, Caiping and Shi, Xiaoliang},
title = {Cell-free DNA screening for trisomies 21, 18, and 13: Clinical application and accuracy evaluation},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0332081}
}
EUVIMED